These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31650797)

  • 1. Clinical Significance of Urinary Neutrophil Gelatinase-associated Lipocalin Levels in Defining the Various Etiologies of Acute Kidney Injury in Liver Cirrhosis Patients.
    Lee JH; Yoon EL; Park SE; Park JY; Choi JM; Jeon TJ; Shin WC; Choi WC
    Korean J Gastroenterol; 2019 Oct; 74(4):212-218. PubMed ID: 31650797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study.
    Allegretti AS; Parada XV; Endres P; Zhao S; Krinsky S; St Hillien SA; Kalim S; Nigwekar SU; Flood JG; Nixon A; Simonetto DA; Juncos LA; Karakala N; Wadei HM; Regner KR; Belcher JM; Nadim MK; Garcia-Tsao G; Velez JCQ; Parikh SM; Chung RT;
    Clin Transl Gastroenterol; 2021 May; 12(5):e00359. PubMed ID: 33979307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.
    Belcher JM; Sanyal AJ; Peixoto AJ; Perazella MA; Lim J; Thiessen-Philbrook H; Ansari N; Coca SG; Garcia-Tsao G; Parikh CR;
    Hepatology; 2014 Aug; 60(2):622-32. PubMed ID: 24375576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study.
    Huelin P; Solà E; Elia C; Solé C; Risso A; Moreira R; Carol M; Fabrellas N; Bassegoda O; Juanola A; de Prada G; Albertos S; Piano S; Graupera I; Ariza X; Napoleone L; Pose E; Filella X; Morales-Ruiz M; Rios J; Fernández J; Jiménez W; Poch E; Torres F; Ginès P
    Hepatology; 2019 Jul; 70(1):319-333. PubMed ID: 30810244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury.
    Gambino C; Piano S; Stenico M; Tonon M; Brocca A; Calvino V; Incicco S; Zeni N; Gagliardi R; Cosma C; Zaninotto M; Burra P; Cillo U; Basso D; Angeli P
    Hepatology; 2023 May; 77(5):1630-1638. PubMed ID: 36125403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for acute kidney injury in decompensated cirrhosis: A prospective study.
    Jaques DA; Spahr L; Berra G; Poffet V; Lescuyer P; Gerstel E; Garin N; Martin PY; Ponte B
    Nephrology (Carlton); 2019 Feb; 24(2):170-180. PubMed ID: 29369449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury and prognosis in decompensated chronic liver disease: A prospective study.
    Yewale RV; Ramakrishna BS; Venugopal G; Doraiswami BV; Rajini K
    Indian J Gastroenterol; 2023 Feb; 42(1):106-117. PubMed ID: 36763249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Neutrophil Gelatinase-Associated Lipocalin in Cirrhotic Patients with Acute Kidney Injury.
    Hamdy HS; El-Ray A; Salaheldin M; Lasheen M; Aboul-Ezz M; Abdel-Moaty AS; Abdel-Rahim A
    Ann Hepatol; 2018 July - August ,; 17(4):624-630. PubMed ID: 29893703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil Gelatinase-associated Lipocalin Predicts Short-term Outcomes in Decompensated Cirrhosis With Acute Kidney Injury.
    Sharan K; Sharma A; Rana S; Patnaik I; Gupta R
    J Clin Exp Hepatol; 2024; 14(1):101274. PubMed ID: 38076377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections.
    Barreto R; Elia C; Solà E; Moreira R; Ariza X; Rodríguez E; Graupera I; Alfaro I; Morales-Ruiz M; Poch E; Guevara M; Fernández J; Jiménez W; Arroyo V; Ginès P
    J Hepatol; 2014 Jul; 61(1):35-42. PubMed ID: 24613364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US.
    Patidar KR; Belcher JM; Regner KR; St Hillien SA; Simonetto DA; Asrani SK; Neyra JA; Sharma P; Velez JCQ; Wadei H; Nadim MK; Chung RT; Seethapathy R; Parada XV; Ouyang T; Ufere NN; Robinson JE; McLean Diaz P; Wilechansky RM; Przybyszewski EM; Smith TN; Ali AA; Orman ES; Schulz P; Siddiqui SM; Shabbir R; Liu LJ; Cama-Olivares A; Flannery AH; Baker ML; Gunasekaran D; Aswine A; Issa R; Li J; Verma S; Chalmers D; Varghese V; Lam W; Mohamed M; Kovacic R; Gaddy A; Attieh RM; Cortes P; Semnani S; Wang L; Khemichian S; Allegretti AS;
    J Hepatol; 2023 Dec; 79(6):1408-1417. PubMed ID: 37517455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary neutrophil gelatinase-associated lipocalin: Acute kidney injury in liver cirrhosis.
    Basthi Mohan P; Nagaraju SP; Rangaswamy D; Musunuri B; Prabhu Attur R; Bhat G; Shailesh ; Shetty S
    Clin Chim Acta; 2021 Dec; 523():339-347. PubMed ID: 34666028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis.
    Patidar KR; Kang L; Bajaj JS; Carl D; Sanyal AJ
    Hepatology; 2018 Jul; 68(1):224-233. PubMed ID: 29315697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute kidney injury in patients with cirrhosis of liver: Clinical profile and predictors of outcome.
    Shetty S; Nagaraju SP; Shenoy S; Attur RP; Rangaswamy D; Rao IR; Mateti UV; Parthasarathy R
    Indian J Gastroenterol; 2018 May; 37(3):248-254. PubMed ID: 30014435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the criteria of hepatorenal syndrome type of acute kidney injury in patients with cirrhosis admitted to ICU.
    Xiong J; Pu L; Xiong H; Xiang P; Zhang M; Liu J; Li A
    Scand J Gastroenterol; 2018 Dec; 53(12):1590-1596. PubMed ID: 30621473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Application of Kidney Biomarkers in Cirrhosis.
    Allegretti AS; Solà E; Ginès P
    Am J Kidney Dis; 2020 Nov; 76(5):710-719. PubMed ID: 32622560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-β-D-glucosaminidase.
    Kim TH; Lee HA; Seo YS; Lee YR; Yim SY; Lee YS; Suh SJ; Jung YK; Kim JH; An H; Yim HJ; Yeon JE; Byun KS; Um SH;
    J Gastroenterol Hepatol; 2019 Jan; 34(1):234-240. PubMed ID: 30062791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysis.
    Puthumana J; Ariza X; Belcher JM; Graupera I; Ginès P; Parikh CR
    Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1003-1013.e3. PubMed ID: 28013112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of urine neutrophil gelatinase-associated lipocalin and renal resistive index in patients of decompensated cirrhosis with acute kidney injury.
    George R; Sonika U; Mahajan B; Sharma A; Dalal A; Sachdeva S; Kumar A
    Dig Liver Dis; 2023 Sep; 55(9):1230-1235. PubMed ID: 37244788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis.
    Verna EC; Brown RS; Farrand E; Pichardo EM; Forster CS; Sola-Del Valle DA; Adkins SH; Sise ME; Oliver JA; Radhakrishnan J; Barasch JM; Nickolas TL
    Dig Dis Sci; 2012 Sep; 57(9):2362-70. PubMed ID: 22562534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.